ULTRALIFE CORP (ULBI) Fundamental Analysis & Valuation

NASDAQ:ULBI • US9038991025

Current stock price

6.9 USD
+0.02 (+0.29%)
Last:

This ULBI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ULBI Profitability Analysis

1.1 Basic Checks

  • In the past year ULBI was profitable.
  • ULBI had a positive operating cash flow in the past year.
  • In multiple years ULBI reported negative net income over the last 5 years.
  • ULBI had a positive operating cash flow in 4 of the past 5 years.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -2.72%, ULBI is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
  • ULBI's Return On Equity of -4.54% is fine compared to the rest of the industry. ULBI outperforms 66.30% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.12%, ULBI is in the better half of the industry, outperforming 68.48% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ULBI is significantly below the industry average of 9.34%.
Industry RankSector Rank
ROA -2.72%
ROE -4.54%
ROIC 3.12%
ROA(3y)1.39%
ROA(5y)0.8%
ROE(3y)1.97%
ROE(5y)1.13%
ROIC(3y)4.13%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20

1.3 Margins

  • ULBI has a Operating Margin of 3.79%. This is in the better half of the industry: ULBI outperforms 67.39% of its industry peers.
  • ULBI's Operating Margin has declined in the last couple of years.
  • ULBI has a Gross Margin (24.07%) which is comparable to the rest of the industry.
  • ULBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.79%
PM (TTM) N/A
GM 24.07%
OM growth 3Y268.41%
OM growth 5Y-6.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.58%
GM growth 5Y-2.35%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ULBI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
  • Compared to 1 year ago, ULBI has about the same amount of shares outstanding.
  • Compared to 5 years ago, ULBI has more shares outstanding
  • Compared to 1 year ago, ULBI has an improved debt to assets ratio.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • ULBI has an Altman-Z score of 1.90. This is not the best score and indicates that ULBI is in the grey zone with still only limited risk for bankruptcy at the moment.
  • ULBI's Altman-Z score of 1.90 is in line compared to the rest of the industry. ULBI outperforms 53.26% of its industry peers.
  • ULBI has a debt to FCF ratio of 6.98. This is a slightly negative value and a sign of low solvency as ULBI would need 6.98 years to pay back of all of its debts.
  • ULBI's Debt to FCF ratio of 6.98 is fine compared to the rest of the industry. ULBI outperforms 71.74% of its industry peers.
  • ULBI has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.35, ULBI is in line with its industry, outperforming 56.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 6.98
Altman-Z 1.9
ROIC/WACC0.39
WACC7.95%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.83 indicates that ULBI has no problem at all paying its short term obligations.
  • ULBI's Current ratio of 2.83 is fine compared to the rest of the industry. ULBI outperforms 72.83% of its industry peers.
  • ULBI has a Quick Ratio of 1.39. This is a normal value and indicates that ULBI is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.39, ULBI is in line with its industry, outperforming 59.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 1.39
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ULBI Growth Analysis

3.1 Past

  • The earnings per share for ULBI have decreased strongly by -45.65% in the last year.
  • The Earnings Per Share has been growing by 71.00% on average over the past years. This is a very strong growth
  • ULBI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.24%.
  • The Revenue has been growing by 12.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-45.65%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%1100%
Revenue 1Y (TTM)16.24%
Revenue growth 3Y13.19%
Revenue growth 5Y12.16%
Sales Q2Q%10.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y279.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.24%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

7

4. ULBI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 27.60, ULBI can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 82.61% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of ULBI to the average of the S&P500 Index (26.77), we can say ULBI is valued inline with the index average.
  • Based on the Price/Forward Earnings ratio of 7.27, the valuation of ULBI can be described as very cheap.
  • 98.91% of the companies in the same industry are more expensive than ULBI, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 21.75. ULBI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 27.6
Fwd PE 7.27
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ULBI is valued cheaper than 92.39% of the companies in the same industry.
  • ULBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ULBI is cheaper than 91.30% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.15
EV/EBITDA 12.18
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.1
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ULBI Dividend Analysis

5.1 Amount

  • No dividends for ULBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ULBI Fundamentals: All Metrics, Ratios and Statistics

ULTRALIFE CORP

NASDAQ:ULBI (4/30/2026, 8:21:33 PM)

6.9

+0.02 (+0.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Industry Strength80.12
Industry Growth68.94
Earnings (Last)03-10
Earnings (Next)05-07
Inst Owners74.9%
Inst Owner Change0.08%
Ins Owners3.21%
Ins Owner Change0.86%
Market Cap114.95M
Revenue(TTM)191.16M
Net Income(TTM)-5.90M
Analysts82.86
Price TargetN/A
Short Float %0.5%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-93.81%
Min EPS beat(2)-131.19%
Max EPS beat(2)-56.43%
EPS beat(4)0
Avg EPS beat(4)-63.41%
Min EPS beat(4)-131.19%
Max EPS beat(4)-15.03%
EPS beat(8)2
Avg EPS beat(8)-34.73%
EPS beat(12)5
Avg EPS beat(12)43.11%
EPS beat(16)7
Avg EPS beat(16)38.18%
Revenue beat(2)0
Avg Revenue beat(2)-18.19%
Min Revenue beat(2)-19.77%
Max Revenue beat(2)-16.62%
Revenue beat(4)1
Avg Revenue beat(4)-9.85%
Min Revenue beat(4)-19.77%
Max Revenue beat(4)3.65%
Revenue beat(8)4
Avg Revenue beat(8)-5.25%
Revenue beat(12)7
Avg Revenue beat(12)1.22%
Revenue beat(16)9
Avg Revenue beat(16)1.59%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 27.6
Fwd PE 7.27
P/S 0.6
P/FCF 16.15
P/OCF 10.46
P/B 0.88
P/tB 1.56
EV/EBITDA 12.18
EPS(TTM)0.25
EY3.62%
EPS(NY)0.95
Fwd EY13.75%
FCF(TTM)0.43
FCFY6.19%
OCF(TTM)0.66
OCFY9.56%
SpS11.47
BVpS7.8
TBVpS4.42
PEG (NY)0.1
PEG (5Y)N/A
Graham Number6.62502 (-3.99%)
Profitability
Industry RankSector Rank
ROA -2.72%
ROE -4.54%
ROCE 4.04%
ROIC 3.12%
ROICexc 3.29%
ROICexgc 4.91%
OM 3.79%
PM (TTM) N/A
GM 24.07%
FCFM 3.72%
ROA(3y)1.39%
ROA(5y)0.8%
ROE(3y)1.97%
ROE(5y)1.13%
ROIC(3y)4.13%
ROIC(5y)N/A
ROICexc(3y)4.36%
ROICexc(5y)N/A
ROICexgc(3y)6.83%
ROICexgc(5y)N/A
ROCE(3y)5.35%
ROCE(5y)N/A
ROICexgc growth 3Y271.58%
ROICexgc growth 5Y-4.24%
ROICexc growth 3Y284.94%
ROICexc growth 5Y-4.14%
OM growth 3Y268.41%
OM growth 5Y-6.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.58%
GM growth 5Y-2.35%
F-Score4
Asset Turnover0.88
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 6.98
Debt/EBITDA 3.57
Cap/Depr 70.41%
Cap/Sales 2.03%
Interest Coverage 1.97
Cash Conversion 86.19%
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 1.39
Altman-Z 1.9
F-Score4
WACC7.95%
ROIC/WACC0.39
Cap/Depr(3y)60.71%
Cap/Depr(5y)59.84%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.65%
EPS 3Y71%
EPS 5YN/A
EPS Q2Q%1100%
EPS Next Y279.44%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.24%
Revenue growth 3Y13.19%
Revenue growth 5Y12.16%
Sales Q2Q%10.55%
Revenue Next Year6.24%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.59%
EBIT growth 3Y317.02%
EBIT growth 5Y4.93%
EBIT Next Year50.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.59%
FCF growth 3YN/A
FCF growth 5Y-17.5%
OCF growth 1Y-33.94%
OCF growth 3YN/A
OCF growth 5Y-12.74%

ULTRALIFE CORP / ULBI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ULTRALIFE CORP (ULBI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ULBI.


What is the valuation status for ULBI stock?

ChartMill assigns a valuation rating of 7 / 10 to ULTRALIFE CORP (ULBI). This can be considered as Undervalued.


What is the profitability of ULBI stock?

ULTRALIFE CORP (ULBI) has a profitability rating of 4 / 10.


What is the valuation of ULTRALIFE CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ULTRALIFE CORP (ULBI) is 27.6 and the Price/Book (PB) ratio is 0.88.